Cargando…

Invasive aspergillosis in patients with severe COVID-19 pneumonia

Detalles Bibliográficos
Autores principales:	Helleberg, Marie, Steensen, Morten, Arendrup, Maiken Cavling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403849/ https://www.ncbi.nlm.nih.gov/pubmed/32768493 http://dx.doi.org/10.1016/j.cmi.2020.07.047

Ejemplares similares

Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap
por: Crone, Cornelia Geisler, et al.
Publicado: (2022)

Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
por: van der Linden, Jan W.M., et al.
Publicado: (2016)

Invasive Aspergillosis among Lung Transplant Recipients during Time Periods with Universal and Targeted Antifungal Prophylaxis—A Nationwide Cohort Study
por: Crone, Cornelia Geisler, et al.
Publicado: (2023)

Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia
por: Lahmer, T., et al.
Publicado: (2020)

Diagnostic Performance of T2Candida Among ICU Patients With Risk Factors for Invasive Candidiasis
por: Arendrup, Maiken Cavling, et al.
Publicado: (2019)

COVID-19-associated invasive pulmonary aspergillosis
por: Rutsaert, Lynn, et al.
Publicado: (2020)

Dissection of the Activity of Agricultural Fungicides against Clinical Aspergillus Isolates with and without Environmentally and Medically Induced Azole Resistance
por: Jørgensen, Karin Meinike, et al.
Publicado: (2021)

Invasive pulmonary aspergillosis in an immunocompetent patient with severe dengue fever
por: Pradhan, Birendra, et al.
Publicado: (2014)

82. Incidence rates of invasive aspergillosis among lung transplant recipients in timeperiods with universal and targeted antifungal prophylaxis - a nationwide cohort study
por: Crone, Cornelia G, et al.
Publicado: (2022)

Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients
por: Lamoth, Frederic, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19
por: Benedetti, María Fernanda, et al.
Publicado: (2022)

Adverse Events Associated with Universal versus Targeted Antifungal Prophylaxis among Lung Transplant Recipients—A Nationwide Cohort Study 2010–2019
por: Crone, Cornelia Geisler, et al.
Publicado: (2022)

Intensive Care Antifungal Stewardship Programme Based on T2Candida PCR and Candida Mannan Antigen: A Prospective Study
por: Helweg-Larsen, Jannik, et al.
Publicado: (2021)

Severe Hypokalemia Precipitated Under Anesthesia Due to Conventional Amphotericin B in a Patient with Invasive Aspergillosis
por: Parida, Satyen, et al.
Publicado: (2021)

Invasive Aspergillosis in Refractory Angioimmunoblastic T-Cell Lymphoma
por: NP, Prakash, et al.
Publicado: (2018)

Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
por: Alanio, Alexandre, et al.
Publicado: (2016)

The association between corticosteroids and aspergillosis among COVID-19 patients
por: Chang, Yi-Hsin, et al.
Publicado: (2023)

Incidence, risk factors, timing, and outcome of influenza versus COVID-19–associated putative invasive aspergillosis
por: Sarrazyn, Camille, et al.
Publicado: (2020)

A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints
por: Astvad, Karen Marie Thyssen, et al.
Publicado: (2022)

Lung mechanics during recovery of a non-invasively ventilated patient with severe COVID-19 pneumonia
por: Lorx, András, et al.
Publicado: (2022)

In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales Order
por: Arendrup, Maiken Cavling, et al.
Publicado: (2015)

Evaluation of MIC Strip Isavuconazole Test for Susceptibility Testing of Wild-Type and Non-Wild-Type Aspergillus fumigatus Isolates
por: Arendrup, Maiken Cavling, et al.
Publicado: (2016)

Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates
por: Georgiou, Panagiota-Christina, et al.
Publicado: (2022)

Invasive Pulmonary Aspergillosis after COVID-19 Pneumonia
por: David, Filipa, et al.
Publicado: (2022)

Cerebral Aspergillosis Complicating COVID Recovery
por: Sampley, Supriya, et al.
Publicado: (2022)

Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data
por: Bassetti, Matteo, et al.
Publicado: (2022)

Invasive Aspergillosis in Patients Treated With Ibrutinib
por: Fürstenau, Moritz, et al.
Publicado: (2020)

Implementation of Isavuconazole in a Fluorescence-Based High-Performance Liquid Chromatography Kit Allowing Simultaneous Detection of All Four Currently Licensed Mold-Active Triazoles
por: Jørgensen, René, et al.
Publicado: (2017)

Severe and treatment-resistant hypocalcemia in patient with bilateral COVID-19 pneumonia()
por: Pla, Begoña, et al.
Publicado: (2021)

Septic shock due to invasive pulmonary aspergillosis without conventional risk factors
por: Shin, Kyung Eun, et al.
Publicado: (2023)

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
por: Fekkar, Arnaud, et al.
Publicado: (2021)

Severe pediatric adenoviral pneumonia combined with invasive pulmonary aspergillosis
por: Huang, Shuihua, et al.
Publicado: (2023)

EUCAST Susceptibility Testing of Isavuconazole: MIC Data for Contemporary Clinical Mold and Yeast Isolates
por: Jørgensen, Karin Meinike, et al.
Publicado: (2019)

Serum cholinesterase associated with COVID-19 pneumonia severity and mortality
por: Nakajima, Kento, et al.
Publicado: (2021)

Diagnosis of Chronic Pulmonary Aspergillosis: Challenges and Limitations Response to “Diagnosis of Chronic Pulmonary Aspergillosis: Which Is the Best Investigation?” and “Diagnosis of Chronic Pulmonary Aspergillosis”
por: De Oliveira, Vítor Falcão, et al.
Publicado: (2023)

Effect of mRNA Vaccines in Preventing COVID-19 Severe Pneumonia Among COVID-19 Patients in Japan
por: Matsuo, Rumi, et al.
Publicado: (2022)

Invasive pulmonary aspergillosis in a patient with metastatic non-small cell lung cancer after treatment with gefitinib
por: Park, Sejeong, et al.
Publicado: (2018)

Hyperglycemic hyperosmolar state associated with invasive rhino-orbital aspergillosis in a patient with end-stage renal disease
por: Seo, Ju Hyun, et al.
Publicado: (2017)

Is the immune hyporesponsiveness of uraemic patients a protective factor for severe COVID-19 pneumonia?()
por: Florit, Enrique A., et al.
Publicado: (2021)

Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
por: Xie, Yun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8ihpd0vb4k841cpj8enit40d53